Trial reportBMC anesthesiology2025
Evaluation of dexmedetomidine as an adjuvant to low-concentration lidocaine/ropivacaine mixtures in ultrasound-guided axillary brachial plexus block.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDexmedetomidine (DEX) can be used with local anesthetics (LAs) to enhance the efficiency of a peripheral nerve block. However, there have been few studies on the combination of DEX and two different LAs for a brachial plexus block (BPB). The effects of adding DEX to low concentrations of lidocaine (LIDO) mixed with ropivacaine (ROP) on block onset, duration of anesthesia, and efficacy of analgesia in ultrasound-guided axillary (UGA) BPB were investigated.
methodsThe study protocol was approved by the Ethics Committee of the Second Affiliated Hospital of Harbin Medical University (ChiCTR-IPR-16007742, January 12, 2016), China. Seventy-five patients designated as American Society of Anesthesiologists Physical Status Classification System I or II and scheduled for forearm or hand surgery were assigned to three groups: (1) R group (n = 25), 0.25% ROP (30 mL) with 0.9% NaCl (3 mL); (2) RL group (n = 25), 0.25% ROP (15 ml) and 0.5% LIDO (15 mL) with 0.9% NaCl (3 mL); and (3) RLD group (n = 25), 0.25% ROP (15 ml) and 0.5% LIDO (15 mL) with DEX (0.75 µg/kg) (3 mL). Data on hemodynamic alterations, the bi-spectral index score (BIS), occurrence and timing of sensory and motor blocks, duration of analgesia, and requirement for rescue analgesia > 48 h were collected.
resultsThe timings of the onsets of sensory and motor blocks were considerably reduced in the RL and RLD groups relative to the R group (p < 0.0001), with no substantial variation between the RL and RLD groups (p > 0.05). Compared with the R and RL groups, the analgesic and block periods in the RLD group were markedly increased (p < 0.0001). The requirement for flurbiprofen rescue intervention was markedly reduced in the RLD group relative to the R and RL groups (p < 0.0001). The BIS was markedly lower in the RLD group, between 20 and 60 min (p < 0.05).
conclusionThe combination of ROP and LIDO led to a reduction in the onset time in UGA BPB. The addition of DEX to ROP/LIDO prolonged the duration of sensory and motor blocks. DEX also resulted in an extension of the analgesia time and provided significant sedation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.